MedTrace Logo

TTNS vs PTNS in a County Hospital System.

NCT07353944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-01-21

No results posted yet for this study

Summary

The goal of this clinical trial is to study whether transcutaneous tibial nerve stimulation (TTNS) is a feasible and satisfactory treatment for overactive bladder in Urogynecology patients who receive their care at a county hospital.

Researchers will compare outcomes with TTNS to patients who undergo percutaneous tibial nerve stimulation (PTNS).

The main questions it aims to answer are:

* Is TTNS non-inferior to PTNS in terms of OAB symptom severity?
* Are patients as satisfied with TTNS as they are with PTNS?
* Are patients' symptoms improved with TTNS?

Participants will:

* either undergo PTNS or be taught how to do TTNS therapy at home
* complete surveys about their bladder symptoms and satisfaction with treatment

Conditions

Interventions

DEVICE

Tibial nerve stimulation

neuromodulation therapy for overactive bladder that targets the posterior tibial nerve

Sponsors & Collaborators

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2018-04-30
Completion
2018-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07353944 on ClinicalTrials.gov